Belle Mead, NJ, United States of America

Mona Patel




Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 59(Granted Patents)


Location History:

  • Wilmington, DE (US) (1999 - 2002)
  • Bridgewater, NJ (US) (2003)
  • Belle Mead, NJ (US) (2003 - 2011)

Company Filing History:


Years Active: 1999-2011

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Mona Patel: Innovator in Pharmaceutical Research and Development

Introduction

Mona Patel is a prominent inventor located in Belle Mead, NJ, recognized for his significant contributions to pharmaceutical innovations. With a remarkable tally of 20 patents, he has made strides in developing novel compounds aimed at treating critical health conditions, particularly those related to metabolic and cardiovascular disorders.

Latest Patents

Among Mona Patel's latest inventions are two noteworthy patents. The first is titled "Dihydroisoindolones as Allosteric Modulators of Glucokinase." This invention encompasses compounds that serve as glucokinase modulators, which are particularly useful in treating disorders such as type II diabetes. The methods include preparation of these compounds and their application in various glucokinase-mediated disorders.

The second patent concerns "Substituted Spiroheterocycles." This innovation focuses on nonpeptide substituted spiroheterobenzazepines that function as vasopressin receptor antagonists. These compounds are designed to address conditions associated with vasopressin receptor activity, including cardiovascular issues such as congestive heart failure, hypertension, and other related disorders.

Career Highlights

Mona Patel's professional journey includes significant positions at leading pharmaceutical companies such as Janssen Pharmaceutica and DuPont Pharmaceuticals Company. His work has profoundly impacted drug development, particularly in the areas concerning the metabolic and cardiovascular health of patients.

Collaborations

Throughout his career, Mona Patel has had the opportunity to collaborate with notable professionals in the field, including Philip J. Rybczynski and Maud J. Urbanski. This collaborative environment has undoubtedly contributed to the richness of innovation and the successful development of his patented compounds.

Conclusion

Mona Patel continues to be an influential force in the pharmaceutical industry, with his innovative studies and patented inventions paving the way for advancements in medical treatments. His dedication to improving human health through scientific discovery remains evident in his body of work and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…